Yuuwa Capital
VC Fund
Perth, Australia
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 56%
- Fund size:
- $37M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Yuuwa Capital invests in
Stages Yuuwa Capital invests in
Countries Yuuwa Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $131k–$808k
- Series A
- $979k–$4.2M
- Series B
- $2.6M–$6.4M
Investment Focus
Industry
- Medical 4 (22%)
- Health Care 4 (22%)
- Biotechnology 4 (22%)
- Software 2 (11%)
- Analytics 2 (11%)
Stage
- Series A 5 (28%)
- Seed 4 (22%)
- Series B 3 (17%)
- Series C 2 (11%)
- Venture - Series Unknown 1 (6%)
Country
- Australia 9 (50%)
- France 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
James Williams
Co-Founder and and Investment Director
|
Co-Founder and and Investment Director | Total investments: 9 | Find email | |
Liddy McCall
Co-Founder and Investment Director
|
Co-Founder and Investment Director | Total investments: 1 | Find email | |
Matthew Macfarlane
Co-Founder and Investment Director
|
Co-Founder and Investment Director | Total investments: 10 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nexgen is an emerging plant trait company delivering non-GM solutions for a range of pathogens, production traits and consumer traits. Our solutions help agriculture-dependent communities around the world improve returns and respond rapidly to emerging opportunities and challenges. The proprietary transformation technique is developing crops thatare virus-resistant; fungal-resistant; salt-tolerant; high in anthocyanin content; and aromatic.These solutions are developing the next generation of globally valued crops for food, fibre, energy and ornamentation. | $2.2M / Venture - Series Unknown / Aug 23, 2018 | ||
| iCetana develops video analytics systems that allow real time reporting of unusual behaviour across an entire camera surveillance network. | $5.9M / Series C / May 09, 2017 | ||
| Agworld, with offices in Perth, Australia, Windsor, CO and Sacramento, CA, provides services in Australia, USA, New Zealand and South Africa with a unique data capture and management platform connecting all major players in the agricultural industry. Agworld allows its users to collect data at all levels and seamlessly share this data with anyonethat is important to them. Agworld users are able to make more profitable decisions due to the data available to them than if they didn't use Agworld. Agworld is available on any iOS device as well as web browser. The Agworld platform is integrated with many other industry players and allows its users to import data from many sources and use this for analyses and reporting. | $3.9M / Series C / Aug 11, 2014 | ||
| Nexgen is an emerging plant trait company delivering non-GM solutions for a range of pathogens, production traits and consumer traits. Our solutions help agriculture-dependent communities around the world improve returns and respond rapidly to emerging opportunities and challenges. The proprietary transformation technique is developing crops thatare virus-resistant; fungal-resistant; salt-tolerant; high in anthocyanin content; and aromatic.These solutions are developing the next generation of globally valued crops for food, fibre, energy and ornamentation. | $1.8M / Series A / Sep 03, 2013 | ||
| iCetana develops video analytics systems that allow real time reporting of unusual behaviour across an entire camera surveillance network. | Series B / Jul 24, 2013 | ||
| Eridan Technology is a Norway-based company that commercializes nanoparticle technology for drug delivery therapies. It is headquartered in Aust-Agder, Norway. | $135K / Seed / Apr 05, 2013 | ||
| PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers. | $6.4M / Series B / Feb 19, 2013 | ||
| Agworld, with offices in Perth, Australia, Windsor, CO and Sacramento, CA, provides services in Australia, USA, New Zealand and South Africa with a unique data capture and management platform connecting all major players in the agricultural industry. Agworld allows its users to collect data at all levels and seamlessly share this data with anyonethat is important to them. Agworld users are able to make more profitable decisions due to the data available to them than if they didn't use Agworld. Agworld is available on any iOS device as well as web browser. The Agworld platform is integrated with many other industry players and allows its users to import data from many sources and use this for analyses and reporting. | $2.6M / Series B / Oct 26, 2012 | ||
| Filter Squad makes the Discovr series of apps: Discovr Music, Discovr Apps, Discovr Movies. Number 1 app in 52 countries including US, Japan, Australia, and across Europe. More than 1.5 million downloads. Featured worldwide by Apple. Listed as one of Billboard 10 Top Music Startups 2011. Winner of Tech23 Greatest Potential Award 2011. Winner ofMIDEM Best Consumer Startup 2011. Featured in the Wall Street Journal, Techcrunch, Mashable, Read Write Web, Gizmodo, Lifehacker, Scobleizer, Macworld, Wired Magazine. | $718K / Seed / Oct 26, 2011 | ||
| Gordiantec is a start-up company and was founded on 25 August 2011. It is a private, unlisted Australian company. The company is funded by capital group Yuuwa Capital LP. Gordiantec is developing applications of a technology implemented by personnel at the University of Western Australia / Western Australian Institute for Medical Research(WAIMR).Gordiantec is validating algorithms for SNP data identification that are associated with disease outcomes and/or population sub-types. Gordiantec has filed or is filing patent applications for diagnostics in areas including diabetes and cancer. It is expanding application of its approach to new diseases. | $808K / Seed / Oct 04, 2011 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Yuuwa Capital invest in?
Yuuwa Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 18 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Yuuwa Capital's check size?
Yuuwa Capital typically joins rounds of $131k–$808k at Seed, $979k–$4.2M at Series A and $2.6M–$6.4M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yuuwa Capital participates in.
How do I contact Yuuwa Capital?
Public channels for Yuuwa Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Yuuwa Capital?
The team at Yuuwa Capital includes James Williams (Co-Founder and and Investment Director), Liddy McCall (Co-Founder and Investment Director) and Matthew Macfarlane (Co-Founder and Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
